1887

Abstract

GB virus B (GBV-B) causes acute hepatitis in experimentally infected tamarins. We compared evolutionary features in acute resolving and persistent GBV-B infection. We detected no evidence of evolution in four animals with clearance during weeks 9–12, whereas three animals with clearance during weeks 13–26 had several substitutions in their polyprotein sequence. A single tamarin had long-term GBV-B viraemia; analysis of virus recovered at weeks 2, 5, 12, 20, 26, 52 and 104 demonstrated that mutations accumulated over time. Overall, the amino acid substitution rate was 3.5×10 and 1.1×10 substitutions per site year during weeks 1–52 and 53–104, respectively. Thus, there was a significant decrease in evolution over time, as found for hepatitis C virus. The rate of non-synonymous substitution per non-synonymous site compared with that of synonymous substitution per synonymous site decreased over time, suggesting reduction of positive selective pressure. These data demonstrate that prolonged GBV-B infection is associated with viral evolution.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.015750-0
2010-03-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/3/727.html?itemId=/content/journal/jgv/10.1099/vir.0.015750-0&mimeType=html&fmt=ahah

References

  1. Bukh J. 2004; A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39:1469–1475 [CrossRef]
    [Google Scholar]
  2. Bukh J., Apgar C. L., Yanagi M. 1999; Toward a surrogate model for hepatitis C virus: an infectious molecular clone of the GB virus-B hepatitis agent. Virology 262:470–478 [CrossRef]
    [Google Scholar]
  3. Bukh J., Engle R. E., Govindarajan S., Purcell R. H. 2008; Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived. J Med Virol 80:87–94 [CrossRef]
    [Google Scholar]
  4. Farci P., Shimoda A., Wong D., Cabezon T., De G. D., Strazzera A., Shimizu Y., Shapiro M., Alter H. J., Purcell R. H. 1996; Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 93:15394–15399 [CrossRef]
    [Google Scholar]
  5. Fernandez J., Taylor D., Morhardt D. R., Mihalik K., Puig M., Rice C. M., Feinstone S. M., Major M. E. 2004; Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity. J Virol 78:9782–9789 [CrossRef]
    [Google Scholar]
  6. Forns X., Thimme R., Govindarajan S., Emerson S. U., Purcell R. H., Chisari F. V., Bukh J. 2000; Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A 97:13318–13323 [CrossRef]
    [Google Scholar]
  7. Kyuregyan K. K., Poleschuk V. F., Zamyatina N. A., Isaeva O. V., Michailov M. I., Ross S., Bukh J., Roggendorf M., Viazov S. 2005; Acute GB virus B infection of marmosets is accompanied by mutations in the NS5A protein. Virus Res 114:154–157 [CrossRef]
    [Google Scholar]
  8. Major M. E., Mihalik K., Fernandez J., Seidman J., Kleiner D., Kolykhalov A. A., Rice C. M., Feinstone S. M. 1999; Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol 73:3317–3325
    [Google Scholar]
  9. Martin A., Bodola F., Sangar D. V., Goettge K., Popov V., Rijnbrand R., Lanford R. E., Lemon S. M. 2003; Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc Natl Acad Sci U S A 100:9962–9967 [CrossRef]
    [Google Scholar]
  10. McGarvey M. J., Iqbal M., Nastos T., Karayiannis P. 2008; Restricted quasispecies variation following infection with the GB virus B. Virus Res 135:181–186 [CrossRef]
    [Google Scholar]
  11. Muerhoff A. S., Leary T. P., Simons J. N., Pilot-Matias T. J., Dawson G. J., Erker J. C., Chalmers M. L., Schlauder G. G., Desai S. M., Mushahwar I. K. 1995; Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 69:5621–5630
    [Google Scholar]
  12. Nam J. H., Faulk K., Engle R. E., Govindarajan S., St.Claire M., Bukh J. 2004; In vivo analysis of the 3′ untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin. J Virol 78:9389–9399 [CrossRef]
    [Google Scholar]
  13. Ogata N., Alter H. J., Miller R. H., Purcell R. H. 1991; Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A 88:3392–3396 [CrossRef]
    [Google Scholar]
  14. Polyak S. J., Khabar K. S., Rezeiq M., Gretch D. R. 2001; Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 75:6209–6211 [CrossRef]
    [Google Scholar]
  15. Sakai A., Takikawa S., Thimme R., Meunier J. C., Spangenberg H. C., Govindarajan S., Farci P., Emerson S. U., Chisari F. V. et al. 2007; In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells. J Virol 81:7208–7219 [CrossRef]
    [Google Scholar]
  16. Simons J. N., Pilot-Matias T. J., Leary T. P., Dawson G. J., Desai S. M., Schlauder G. G., Muerhoff A. S., Erker J. C., Buijk S. L., Chalmers M. L. 1995; Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A 92:3401–3405 [CrossRef]
    [Google Scholar]
  17. Takikawa S., Engle R. E., Emerson S. U., Purcell R. H., St. Claire M., Bukh J. 2006; Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein. Proc Natl Acad Sci U S A 103:3345–3350 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.015750-0
Loading
/content/journal/jgv/10.1099/vir.0.015750-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error